|
THERAPEUTIC APPROACHES FOR
GENITAL WARTS
Treatment goals
External genital warts should be treated because of the rare but real risk
of progression to cancer as well as to reduce the possibility of HPV
transmission and relieve patients of the psychosexual burden they may
experience. The ideal outcome of treatment for genital warts would be complete
viral eradication. However, this ideal is not attainable, so elimination of the
visible wart is the current treatment goal. Visible wart tissue is thought to
harbour high numbers of virions. Therefore, removing visible warts should
reduce the viral load, thereby reducing viral transmission. Other therapeutic
goals include prolonging disease-free periods and minimising the risk of
malignant transformation.
Current therapeutic approaches: an overview
Current therapies for condylomata are limited to destruction of visible
warts. Treatments may be categorised as topical, ablative, surgical or
intralesional. Laser therapy and systemic or intralesional interferon
injections are used less frequently than other treatments. Unfortunately,
existing therapies do not yield a 100% response rate; in addition, recurrence
rates are high and no current therapies eliminate the causative agent
(Table 2). Many therapies require multiple and often
painful treatments, and all have disadvantages.
The number of treatment modalities and their limitations complicates
therapy, which must be individualised according to severity, anatomical
location and clinical course. Additionally, probable side effects, patient
tolerance, compliance, effectiveness, cost and the cost-benefit ratio of
treatment must be considered. Furthermore, because HPV can often be found in
adjacent normal skin and HPV DNA may remain in the basal layer as a reservoir
of infection, warts often recur after treatment. Recurrence rates have ranged
widely in clinical studies but recurrence appears to be common with current
therapies. Recurrence may result from subclinical or latent infection in the
patient or from reinfection by an infected partner. Indeed, new warts may begin
to appear before the previous treatment site has healed.

Genital warts
Table 1. Current treatments for genital warts
Topical
Podophyllin resin
Podophyllotoxin
Trichloroacetic acid
5-FU cream
Ablative
Cryotherapy
Electrosurgery
C02 laser
Surgical
Excision
Intralesional
Interferon-a
Interferon-ß
AccuSite( Injectable Gel
Table 2. Analysis of current treatments for genital
warts
Treatment
|
Clearance rate
|
Recurrence
|
Topical
|
|
|
podophyllin resin (10%-25%)
|
32-79%
|
27-65%
|
podophyllotoxin (podofilox) (0.5%)
|
45-88%
|
33-60%
|
trichloroacetic acid (TCA)
|
81%
|
36%
|
5-FU cream
|
41-68%(women)
|
0-10% (after 6-12 months)
|
Ablative
|
|
|
electrosurgery
|
94%
|
22%
|
cryotherapy
|
63-88%
|
21%-39%
|
C02 laser
|
31-94%
|
3%-95%
|
Intralesional
|
|
|
Interferon-a
|
36%(n=257)
|
21%(n=257)
|
Surgical
|
|
|
Excision
|
93%
|
29%
|
|